(Q53624010)
Statements
4-1BB promotes long-term survival in skin allografts treated with anti-CD45RB and anti-CD40L monoclonal antibodies. (English)
Lee J
Lee EN
Kim EY
Lee HJ
Park HJ
Sun CL
Lee SK
Lee KW
Kwon GY
Kim SJ
1 January 2005
37
1
123-125
2 references
1 reference
1 reference
1 reference
1 reference
1 reference